Join us! An ideal venue to explore the innovation and - PowerPoint PPT Presentation

Join us! An ideal venue to explore the innovation and partnering opportunities in Latin America’s rapidly- growing biotechnology industry. Join stakeholders from around the globe to discuss Why Attend trends, navigate industry challenges, attend company presentations, conduct 1x1 partnering meetings and learn about investment opportunities within this  GAIN UNPARALLELED ACCESS to life science, industrial, biochemical emerging market. and environmental products and technologies from across Latin America;  Be at the forefront of THE LATEST INDUSTRY INNOVATIONS ;  Arrange UNLIMITED FACE-TO-FACE MEETINGS with high-value potential partners;  Learn about the venture capital industry and other FUNDING POSSIBILITIES IN LATIN AMERICA ;  Engage local government bodies, industry clusters and companies that will help you to SUCCEED IN THE LATIN AMERICA LIFE SCIENCES MARKET .

Expected Facts & Figures 3.000+ 700+ 30+ 30+ 400+ 20 + 20+ Meeting Attendees Countries Investment Companies Startup Discussion Requests Funds/Groups Presentations Sessions BLA 2019 (Expectation) EVOLUTION 2014 2015 2016 2018 Attendees 462 559 577 621 700 400 Companies 256 288 318 325 30 Countries 25 24 28 20 3.000 Meetings 1.337 1.753 2.354 2.542

Who Attends Join decision makers, business stakeholders and innovation agents, such as:  Industry executives;  Entrepreneurs & Startups;  Investors & Financiers;  Researchers, Universities & Research Centers;  Accelerators, Incubators and Associations;  Government Representatives;  Service Providers (Consultants, IP Firms, Trade Offices, etc.);  Among others … 1% 8%2% C-Level (CEO, CFO, CSO, COO, Chairman, Latin America 23% Founder, Partner, President, VP, GM, etc.) 30% US & Canada 16% Executive Level (Director, Manager, BD, Head, Europe Lead, Coordinador, etc.) Asia 73% Other (Analyst, Advisor, Professor, Rest of World Researcher, Specialist, Consultant, etc.) 47%

Diferentials NETWORKING STARTUPS INTERNATIONAL EXPERIENCES Valuable opportunity to meet and Get to know the geography of Life Stay on top of what's happening around interact with key players in the Life Sciences innovation in Latin America the world, learning and inspiring from Sciences sector, such as large companies, through startups that are creating high who's at the forefront of global hospitals, laboratories, universities, impact solutions, as well as companies innovation. The event will count with public agencies, investors and that have already worked their way to outstanding participation of speakers entrepreneurs. success. from the international scene.

Business Opportunities MEET POTENTIAL PARTNERS Pre-schedule face-to-face meetings via the BIO One-on- One Partnering System™ DISCOVER NEW TECHNOLOGIES The Startup Competition will create a platform for innovative startups to tell their story to an influential audience, and ultimately foster the development of important new technologies that will expand the industry’s pipeline. LEARN ABOUT THE INDUSTRY Panels discussions on subjects of interest to the life sciences sector, and learn about investment opportunities within this exciting market. BRANDING OPPORTUNITIES Exhibiting offers greater visibility to conference’s attendees, fostering increased interaction with potential clients, suppliers and investors.

Discussing Bioeconomy Innovation SEGMENTS: Human Animal Food & Bioinformatics Industrial Biotech Environment & Health Health Agritech & Cosmetics Natural Resources TOPICS: Market Investment & Regulatory International Human Intellectual Opportunities Financing Environment Cooperation Capital Property

Conference Structure INNOVATION EXHIBIT PARTNERING ARENA PARTNERING INNOVATION EXHIBIT ARENA AUDITORIUM AUDITORIUM

Program Structure SEPTEMBER 3 - 4 08:30 – 18:00 Check-in & Registration 09:00 – 09:15 Welcome Address 09:15 – 10:30 Opening Keynote 10:30 – 12:00 Plenary Session Innovation Arena 12:00 – 13:00 Business Lunch (sponsors/startups/ BIO One-on-One institutions booths) Partnering™ Meetings (Scheduled in 30-min Track Track 13:00 – 17:00 intervals) Human & Animal Health AgBio + I&E 17:00 – 18:00 Startup Stadium 18:00 – 21:00 Networking Cocktail

Media Highlights

1 st Ranked in

Digital Marketing Reach +6,000 +44,200 People reached with the sending of 13 emails People reached with the sending of 8 emails marketing by Biominas in 2018. marketing by BIO in 2018. 14,933 45,858 Reach of the 60 posts made at Biominas Reach of the 82 posts made at Biominas and BLA LinkedIn pages in 2018. Facebook account in 2018. 212 #biolatinamerica Publications/posts made by supporters, partners and the press in 2018.

Our Social Medias 15,347 1,824 Followers of BIO’s Facebook account Followers of Biominas’ Facebook account @IAmBiotech @BiominasBrasil 524 4,648 Followers of BLA’s LinkedIn account Followers of Biominas’ LinkedIn account @BioLatinAmerica @BiominasBrasil 87,400 1,333 Followers of BIO’s Twitter account Followers of Biominas’ Twitter account @IAmBiotech @Biominas

Companies/Institutions that Presented in 2018  AbbVie  DASA  Ministério da Saúde (Brazil)  ABL-Therapeutic  Di Blasi, Parente & Associados  Ministério do Desenvolvimento, Indústria e  Adarna Health Data  Embrapa Comércio Exterior (Brazil)  Naiad  ADITIV LAB  EMBRAPII  NanoPack  Agroicone  Eurofarma  Olivares  Allbiotech  Genera  Orygen Biotecnologia  Anvisa (Brazil)  General Health Council (Mexico)  Performa Investimentos  Apex-Brasil  Global Innovation Policy Center  Pfizer  Arborea Biotech  ImplantCell  Phytobios  Aya Tech  In Situ Terapia Celular 60+  Pluricell  Biotechnology Innovation Organization (BIO)  inNano  PróMexico  Biominas Brasil  INPI (Argentina) speakers  Pro-Therapeutics  Biomm  INPI (Brazil)  RG Solutions (Nutrinovapharma)  Biopolix Materiais Tecnológicos  InSiChem Drug Discovery  SEBRAE  Biored Brasil  Instituto SENAI de Inovação em  Signal  Biosolvit Biossintéticos  Integra Bioprocessos e Análises  Sociedade Brasileira de Reumatologia  BNDES  Intrexon  Syngenta  Bolsa de Cereales (Argentina)  IQVIA  SYNOVA/CAEP  Braskem  Johnson & Johnson Innovation  Tecpar  Centro de Informação de Biotecnologia  Kestener, Granja & Vieira Advogados  Vitta Tecnologia em Saúde S.A.  CLAPBio  LOTAN Agrosciences  YLive Biotecnologia  Cuco Health

Highlighted Speakers (past editions)  Om Arora, Latin America Regional Head, Pfizer INDUSTRY  Adam Monroe, President, Novozymes Americas  Rogerio Ribeiro, SVP Emerging Markets, GSK  Andreas Baumann, Director for Global Early Development, Bayer  Sekhar Boddupalli, President, Intrexon Crop Protection  Andrew Robertson, Director for US Regulatory Policy, Merck & Co  Sridhar Gopal, International Head of Business Development, AbbVie  Andrew Simpson, Scientific Director, Orygen Biotecnologia  Tom Luby, Head of JLABS @ Texas Medical Center, Johnson & Johnson  Atul Thakrar, President, DSM Biobased Products & Services Innovation  Bernardo Gradin, Chief Executive Officer, GranBio  Filipe Teixeira, Legal Director, Syngenta INVESTMENT / FINANCING  Hadyn Parry, CEO, Oxitec  Alan Vanderborght, CEO, Kybora Emerging Markets  Heraldo Marchezini, CEO, Biomm  Andrew Callaway, Managing Director, Healthcare Investment Banking /  Hubert Guarino, General Manager for Brazil, Sanofi Pasteur Deutsche Bank  John Biggs, R&D Director Latin America, Dow  Fernando Reinach, Managing Partner, Fundo Pitanga  John Melo, President & CEO, Amyris  Fred Aslan, Vice President, Venrock Associates  Juan Conde, General Manager for Brazil, Baxalta  Gabriela Cezar, CEO & Principal Partner, Panarea Partners  Kelly Anderson, Director of International Policy, GIPC  Guilherme Emrich,  Marco Billi, M&A/Corporate Venture, Eurofarma  Guillaume Sagez, Managing Partner, Performa Investimentos  María Eugenia Sánchez, Regional Director Clinical Ops Latin America, Lilly  Jayme Queiroz, Investment Officer, Apex-Brasil  Maria Paula Marques, VP for Regulatory and Scientific Affairs, Allergan  Roel Collier, Principal, TPG ART  Marité Prieto, Regulatory Affairs, Safety and Compliance Director, Amgen  Thomas Gerlach, Director, BBI Financial